Peijia Medical Limited Asset Resilience Ratio

Latest as of December 2025: 0.51%

Peijia Medical Limited asset resilience ratio. Peijia Medical Limited (4WO) has an Asset Resilience Ratio of 0.51% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Peijia Medical Limited (4WO) defensive interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

€13.53 Million
≈ $15.82 Million USD Cash + Short-term Investments

Total Assets

€2.66 Billion
≈ $3.11 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Peijia Medical Limited (2019–2025)

Asset resilience ratio of Peijia Medical Limited from 2019 to 2025. This chart shows how Peijia Medical Limited's Asset Resilience Ratio has changed over time. Read total liabilities of Peijia Medical Limited for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Peijia Medical Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Peijia Medical Limited asset portfolio.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €0.00 0%
Short-term Investments €13.53 Million 0.51%
Total Liquid Assets €13.53 Million 0.51%

Asset Resilience Insights

  • Limited Liquidity: Peijia Medical Limited maintains only 0.51% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Peijia Medical Limited Industry Peers by Asset Resilience Ratio

Compare Peijia Medical Limited's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shenzhen New Industries Biomedical
SHE:300832
Medical Devices 9.95%
Double Medical Technology Inc
SHE:002901
Medical Devices 12.59%
BMC Medical Co. Ltd. A
SHE:301367
Medical Devices 44.96%
Emvision Medical Devices Ltd
AU:EMV
Medical Devices 0.06%
Hironic Co. Ltd
KQ:149980
Medical Devices 17.42%
DRGEM Corporation
KQ:263690
Medical Devices 2.12%
Oncosil Medical Ltd
AU:OSL
Medical Devices 0.00%
Adherium Ltd
AU:ADR
Medical Devices 15.45%

Peijia Medical Limited Asset Resilience Ratio by Year (2019–2025)

Peijia Medical Limited asset resilience ratio by year from 2019 to 2025. The table below shows the annual Asset Resilience Ratio data for Peijia Medical Limited.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 0.51% €13.53 Million
≈ $15.82 Million
€2.66 Billion
≈ $3.11 Billion
-1.19pp
2024-12-31 1.70% €45.78 Million
≈ $53.53 Million
€2.69 Billion
≈ $3.14 Billion
-3.80pp
2023-12-31 5.51% €147.16 Million
≈ $172.04 Million
€2.67 Billion
≈ $3.12 Billion
+3.35pp
2022-12-31 2.16% €71.56 Million
≈ $83.67 Million
€3.32 Billion
≈ $3.88 Billion
+2.04pp
2020-12-31 0.11% €3.26 Million
≈ $3.81 Million
€2.88 Billion
≈ $3.37 Billion
-1.59pp
2019-12-31 1.71% €15.00 Million
≈ $17.54 Million
€879.48 Million
≈ $1.03 Billion
--
pp = percentage points

About Peijia Medical Limited

F:4WO Germany Medical Devices
Market Cap
$299.00 Million
€255.75 Million EUR
Market Cap Rank
#14522 Global
#1466 in Germany
Share Price
€0.38
Change (1 day)
-2.05%
52-Week Range
€0.38 - €0.78
All Time High
€3.90
About

Peijia Medical Limited, together with its subsidiaries, engages in the research, development, manufacturing, and sales of transcatheter valve therapeutic and neurointerventional procedural medical devices in the People's Republic of China. It operates through Transcatheter Valve Therapeutic Business, Neurointerventional Business, and Future Technology Business segments. The company's products inc… Read more